Home Newsfeeds JP Morgan Downgrades FedEx to Neutral, Lowers Price Target to $214

JP Morgan Downgrades FedEx to Neutral, Lowers Price Target to $214

JP Morgan analyst Brian Ossenbeck downgrades FedEx (NYSE:FDX) from Overweight to Neutral and lowers the price target from $258 to $214.

byBenzinga Newsdesk

September 16, 2022

1 minute read

JP Morgan analyst Brian Ossenbeck downgrades FedEx (NYSE:FDX) from Overweight to Neutral and lowers the price target from $258 to $214.

News
Tech

OpenAI Investor Vinod Khosla Works 80 Hours A Week, Will Use Peter Thiel’s Anti-Aging Methods If They Work

By Rounak Jain

December 1, 10:27 PM

Vinod Khosla says he is still passionate about his work and wants to continue doing so for the next 25 years.

KVSA

Hydrogen Highway: Stellantis Gears Up With In-House Production Of Eco-Friendly Commercial Vans In Europe

By Lekha Gupta

January 29, 2:24 PM

Stellantis NV begins volume production of hydrogen fuel cell vans in France and Poland, expanding its line of zero-emission commercial vehicles.

STLA

Medicenna To Present 4 Year Follow-Up Phase 2b Bizaxofusp Survival Data In Recurrent Glioblastoma At The Society For Neuro-Oncology 2023 Annual Meeting

By Benzinga Newsdesk

November 9, 10:15 AM

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX:MDNA, OTC:MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, today announced that a poster presentation and an oral

MDNA

Mizuho Downgrades Essex Property Trust to Neutral, Lowers Price Target to $264

By Benzinga Newsdesk

September 19, 7:01 AM

Mizuho analyst Haendel St. Juste downgrades Essex Property Trust (NYSE:ESS) from Buy to Neutral and lowers the price target from $314 to $264.

ESS

JP Morgan Downgrades FedEx to Neutral, Lowers Price Target to $214

Related Posts

OpenAI Investor Vinod Khosla Works 80 Hours A Week, Will Use Peter Thiel’s Anti-Aging Methods If They Work

Hydrogen Highway: Stellantis Gears Up With In-House Production Of Eco-Friendly Commercial Vans In Europe

Medicenna To Present 4 Year Follow-Up Phase 2b Bizaxofusp Survival Data In Recurrent Glioblastoma At The Society For Neuro-Oncology 2023 Annual Meeting

Mizuho Downgrades Essex Property Trust to Neutral, Lowers Price Target to $264